BioInvent International AB (publ)

OM:BINV Stock Report

Market Cap: SEK 1.8b

BioInvent International Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BINV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders244,4730.372%
Hedge Funds10,018,75615.2%
Institutions10,751,86516.3%
General Public20,068,78530.5%
VC/PE Firms24,720,48337.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.2%
Redmile Group, LLC
10,018,756SEK 280.5m0%2.21%
13.7%
Van Herk Investments B.V.
9,039,487SEK 253.1m0%3.28%
9.81%
Forbion Capital Partners B.V.
6,457,785SEK 180.8m0%3.56%
7.71%
HBM Partners Ltd.
5,075,000SEK 142.1m0%1.33%
6.3%
Omega Fund Management, LLC
4,148,211SEK 116.1m0%5.02%
6.11%
Fourth Swedish National Pension Fund (AP4)
4,023,281SEK 112.7m0%0.06%
2.79%
Avanza Fonder AB
1,832,694SEK 51.3m0%0.04%
2.5%
The Goldman Sachs Group, Inc.
1,648,340SEK 46.2m0%no data
1.93%
Handelsbanken Asset Management
1,269,672SEK 35.6m0%0.01%
0.68%
Rhenman & Partners Asset Management AB
450,000SEK 12.6m0%0.12%
0.65%
E. Öhman J:or Wealth Management
429,015SEK 12.0m0%0.01%
0.54%
SEB Investment Management AB
355,717SEK 10.0m0%no data
0.51%
Skandia Fonder AB
333,832SEK 9.3m0%0.01%
0.35%
FCG Fonder AB
229,215SEK 6.4m0%0.06%
0.19%
Dimensional Fund Advisors LP
123,877SEK 3.5m4.26%no data
0.1%
Bernd Seizinger
66,000SEK 1.8m0%no data
0.076%
Storebrand Fonder AB,
49,781SEK 1.4m0%no data
0.044%
Kristoffer Bissessar
29,000SEK 812.0k0%no data
0.042%
Leonard Kruimer
27,538SEK 771.1k0%no data
0.035%
Björn Frendéus
23,089SEK 646.5k0%no data
0.035%
Sylvie Ryckebusch
22,870SEK 640.3k0%no data
0.034%
Martin Welschof
22,400SEK 627.2k0%no data
0.034%
Kristoffer Hansson
22,303SEK 624.4k0%no data
0.027%
Erik Esveld
18,000SEK 503.9k0%no data
0.012%
Stefan Ericsson
8,000SEK 224.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 20:31
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioInvent International AB (publ) is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Camilla OxhamreCarnegie Investment Bank AB
Mattias HäggblomDanske Bank